Ultima-Anomass 400 Mix Ultima Pharmaceuticals

£100.00

Ultima-Anomass 400 Mix is a multi-compound injectable blend designed for comparative pharmacokinetic research studies. This laboratory-grade solution enables researchers to examine complex anabolic pathways in controlled experimental conditions.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-Anomass 400 Mix Ultima Pharmaceuticals
Ultima-Anomass 400 Mix Ultima Pharmaceuticals
£100.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Product Overview: Ultima-Anomass 400 Mix Ultima Pharmaceuticals

Ultima-Anomass 400 Mix is a multi-compound anabolic steroid blend formulated by Ultima Pharmaceuticals for advanced pharmaceutical research applications. This injectable solution contains a precisely calibrated combination of testosterone esters, trenbolone acetate, and drostanolone propionate at 400mg/ml concentration, enabling researchers to investigate complex androgenic and anabolic pathway interactions in laboratory settings. The formulation provides researchers at Stroid UK Shop with a standardised multi-compound reference material for comparative pharmacological studies examining synergistic effects between different anabolic agents.

Laboratory Applications

This multi-ester blend enables comprehensive research into anabolic steroid pharmacokinetics, tissue distribution patterns, and metabolic pathway analysis. Researchers can examine how different ester chain lengths affect compound bioavailability and clearance rates in experimental models. The combination allows for studies investigating androgenic receptor binding competition, aromatisation pathway modulation, and DHT-derived compound interactions. Academic institutions studying steroid biochemistry utilise such blends to evaluate complex pharmacodynamic relationships that cannot be observed with single-compound preparations. The formulation supports research into advanced pharmaceutical compounds and their metabolic fate in biological systems.

Technical Specifications

Ultima-Anomass 400 Mix Research Specifications
Parameter Specification
Concentration 400mg/ml multi-compound blend
Manufacturer Ultima Pharmaceuticals
Form Injectable oil solution
Storage Room temperature, protect from light
Solvent Pharmaceutical-grade carrier oil
Research Grade Laboratory reference standard

The solution demonstrates excellent stability under proper storage conditions and maintains compound integrity for extended research protocols. Each vial provides sufficient volume for multiple analytical assays and chromatographic analysis. Researchers investigating selective androgen modulators often use such multi-compound blends as comparison standards, while those studying peptide hormones utilise them to examine interaction pathways between different hormonal signalling systems.

Regulatory Compliance

This product is supplied exclusively for in-vitro research purposes and analytical chemistry applications. Ultima-Anomass 400 Mix is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with local regulations governing controlled substances and maintain appropriate laboratory safety protocols during handling and analysis.

Related